# Intrathecal Hydromorphone for Pain Control After Cesarean Section

> **NCT02096003** · PHASE2 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 80 (actual)

## Conditions studied

- Pain
- Cesarean Section

## Interventions

- **DRUG:** Intrathecal morphine
- **DRUG:** Intrathecal hydromorphone

## Key facts

- **NCT ID:** NCT02096003
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2017-05-05
- **Final completion:** 2017-05-05
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2019-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02096003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02096003, "Intrathecal Hydromorphone for Pain Control After Cesarean Section". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02096003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*